Supernus Pharmaceuticals: Q3 Earnings Insights

Supernus Pharmaceuticals (NASDAQ:SUPN) reported its Q3 earnings results on Wednesday, November 3, 2021 at 04:00 PM.

Here's what investors need to know about the announcement.

Supernus Pharmaceuticals their estimated earnings by 73.91%, reporting an EPS of $0.4 versus an estimate of $0.23, which surprised analysts.

Revenue was up $6,671,000 from the same period last year.

Last quarter the company beat on EPS by $0.23, which was followed by a 2.17% drop in the share price the next day.

Here's a look at Supernus Pharmaceuticals's past performance:

Quarter	Q2 2021	Q1 2021	Q4 2020	Q3 2020
EPS Estimate	0.20	0.24	0.52	0.30
EPS Actual	0.43	0.11	0.57	0.74
Revenue Estimate	134.87M	129.20M	146.19M	130.66M
Revenue Actual	141.33M	130.93M	143.56M	155.13M

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.